FPH2
CAS No. 957485-64-2
FPH2 ( BRD-9424 )
产品货号. M17692 CAS No. 957485-64-2
FPH2 (BRD-9424) 是一种促进 iPS 衍生肝细胞分化的小分子。
纯度: >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| 规格 | 价格/人民币 | 库存 | 数量 |
| 2MG | ¥245 | 有现货 |
|
| 5MG | ¥378 | 有现货 |
|
| 10MG | ¥651 | 有现货 |
|
| 25MG | ¥1423 | 有现货 |
|
| 50MG | ¥2474 | 有现货 |
|
| 100MG | ¥3591 | 有现货 |
|
| 500MG | 获取报价 | 有现货 |
|
| 1G | 获取报价 | 有现货 |
|
| 1 mL x 10 mM in DMSO | ¥432 | 有现货 |
|
生物学信息
-
产品名称FPH2
-
注意事项本公司产品仅用于科研实验,不得用于人体或动物的临床与诊断
-
产品简述FPH2 (BRD-9424) 是一种促进 iPS 衍生肝细胞分化的小分子。
-
产品描述FPH2 (BRD-9424) is a small molecule promoting differentiation of iPS-derived hepatocytes.
-
体外实验FPH2 induces functional proliferation of hepatocytes in vitro, and thus may be useful for expanding mature human primary hepatocytes. FPH1 and FPH2 can increase in hepatocyte nuclei count and/or elevate the number of nuclei undergoing mitosis during primary screening, and these effects on hepatocytes are concentration dependent. Cells treated with FPH1 and FPH2 also maintain their liver-specific functions. Over 7 days, FPH2 induces hepatocyte doublings at a rate that is consistent with reported liver regeneration kinetics in vivo.
-
体内实验——
-
同义词BRD-9424
-
通路MAPK/ERK Signaling
-
靶点p38 MAPK
-
受体Others
-
研究领域Others-Field
-
适应症——
化学信息
-
CAS Number957485-64-2
-
分子量353.83
-
分子式C14H16ClN5O2S
-
纯度>98% (HPLC)
-
溶解度DMSO : ≥ 125 mg/mL; 353.28 mM
-
SMILESClc1cc(NC(=S)Nc2cn(nc2C(=O)N)CC)c(OC)cc1
-
化学全称——
运输与储存
-
储存条件(-20℃)
-
运输条件With Ice Pack
-
稳定性≥ 2 years
参考文献
1. Shan J, et al. Nat Chem Biol. 2013, 9(8), 514-520.
产品手册
关联产品
-
CC-99677
Gamcemetinib (CC-99677) 是一种有效的、共价的、不可逆的丝裂原活化蛋白 (MAP) 激酶活化蛋白激酶 -2 (MK2)通路抑制剂,在生化(IC50=156.3 nM) 和细胞基础检测 (EC50=89 nM) 中均有作用。Gamcemetinib 来自专利 WO2020236636,化合物 1。
-
p38-α MAPK-IN-1
p38-α MAPK-IN-1 是一种 MAPK14 (p38-α) 抑制剂,在 EFC 置换试验和 HTRF 试验中 IC50 分别为 2300 nM 和 5500 nM。
-
TA-02
一种有效的 p38 MAPK 抑制剂,IC50 为 20 nM。
021-51111890
购物车()
sales@molnova.cn

